Drug intelligence / Profile preview

Collomak

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Topical
01

Overview

**Collomak** is a topical solution containing **salicylic acid (2% w/w)**, **lactic acid (0.5% w/w)**, and **polidocanol (0.2% w/w)** formulated for the treatment of warts, corns, and calluses. It acts as a keratolytic agent: salicylic acid softens and dissolves keratin to promote peeling of hyperkeratotic tissue; lactic acid reduces hyperkeratosis, induces epidermolysis to destroy wart tissue and virus; polidocanol serves as a local anesthetic to minimize pain during application. Originally developed by **Heinrich Mack Nachf (Germany)**, it is applied daily to affected areas after soaking in warm water, with treatment durations up to 12 weeks for warts. Systemic absorption is low (9-25% for salicylic acid), and it is marketed in regions including Nigeria by **Smart way Pharma** and manufactured by **October Pharma S.A.E. (Egypt)**.[1][3][4][6]

Brand names
Collomak

Beyond the preview

Go deeper on Collomak.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collomak.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call